Related Experiment Video
Updated: Jul 4, 2026
05:14
A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
[Chemotherapy-induced cardiotoxicity in the elderly].
Michel Bernard1, Danièle Avenin, Frédéric Selle
1Service de cardiologie, hôpital Tenon, Université Pierre et Marie Curie, 75020 Paris, France.
Bulletin Du Cancer
|December 17, 2008
Summary
Chemotherapy can harm heart function, similar to aging. Early detection using echocardiography and a new vulnerability score can help manage risks and prevent complications in patients undergoing cancer treatment.
Area of Science:
- Cardiology
- Oncology
- Gerontology
Background:
- Chemotherapy can induce cardiotoxicity, leading to systolic/diastolic dysfunction, hypertension, and arrhythmias.
- Cardiac and vascular aging share similar detrimental effects, often exacerbated by vascular risk factors.
- Understanding the interplay between chemotherapy-induced cardiotoxicity and aging is crucial for patient management.
Purpose of the Study:
- To analyze the correlation between chemotherapy-induced cardiotoxicity and cardiac/vascular aging.
- To investigate preventive and early treatment strategies for patients at risk.
- To introduce a novel vulnerability score for predicting chemotherapy-related cardiac complications.
Main Methods:
- Echocardiography is highlighted for assessing systolic and diastolic cardiac function.
- Stress echocardiography is proposed for evaluating impaired contractility and ischemic heart disease risk.
- Development of a predictive vulnerability score for chemotherapy complications.
Main Results:
- Echocardiography plays a key role in monitoring chemotherapy-induced cardiac changes.
- Stress echo aids in assessing functional capacity and vascular risk.
- A vulnerability score can identify patients at higher risk of cardiotoxicity.
Conclusions:
- Early and comprehensive cardiac assessment is vital for patients receiving chemotherapy.
- Integrating echocardiography and risk stratification can optimize patient care.
- Proactive management strategies are essential to mitigate chemotherapy-related cardiovascular risks.
Related Concept Videos
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
01:26Heart Failure Drugs: Inotropic Agents
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...